UTHR logo

United Therapeutics (UTHR) Current Assets

Annual Current Assets

$3.55 B
+$170.70 M+5.05%

31 December 2023

UTHR Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$4.00 B
+$380.90 M+10.52%

30 September 2024

UTHR Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

UTHR Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+12.7%
3 y3 years+52.8%+72.2%
5 y5 years+90.5%+114.6%

UTHR Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+63.9%at high+72.2%
5 y5 yearsat high+100.8%at high+116.7%
alltimeall timeat high>+9999.0%at high>+9999.0%

United Therapeutics Current Assets History

DateAnnualQuarterly
Sept 2024
-
$4.00 B(+10.5%)
June 2024
-
$3.62 B(+11.4%)
Mar 2024
-
$3.25 B(-8.5%)
Dec 2023
$3.62 B(+35.7%)
$3.55 B(+2.7%)
Sept 2023
-
$3.46 B(+7.6%)
June 2023
-
$3.21 B(+0.6%)
Mar 2023
-
$3.19 B(-5.5%)
Dec 2022
$2.66 B(-6.4%)
$3.38 B(+10.6%)
Sept 2022
-
$3.06 B(+13.9%)
June 2022
-
$2.68 B(+3.8%)
Mar 2022
-
$2.59 B(+11.3%)
Dec 2021
$2.85 B(+16.2%)
$2.32 B(-2.6%)
Sept 2021
-
$2.39 B(+2.9%)
June 2021
-
$2.32 B(+15.1%)
Mar 2021
-
$2.01 B(-7.1%)
Dec 2020
$2.45 B(+19.5%)
$2.17 B(+16.0%)
Sept 2020
-
$1.87 B(-1.4%)
June 2020
-
$1.89 B(+2.6%)
Mar 2020
-
$1.85 B(-1.0%)
Dec 2019
$2.05 B(+25.5%)
$1.86 B(-3.6%)
Sept 2019
-
$1.93 B(-9.6%)
June 2019
-
$2.14 B(+10.2%)
Mar 2019
-
$1.94 B(+9.9%)
Dec 2018
$1.63 B(+14.1%)
$1.77 B(+9.9%)
Sept 2018
-
$1.61 B(-1.0%)
June 2018
-
$1.62 B(-0.6%)
Mar 2018
-
$1.63 B(+12.8%)
Dec 2017
$1.43 B(+58.9%)
$1.45 B(-11.7%)
Sept 2017
-
$1.64 B(+4.8%)
June 2017
-
$1.56 B(+4.0%)
Mar 2017
-
$1.50 B(+5.6%)
Dec 2016
$900.80 M(-0.9%)
$1.42 B(+2.8%)
Sept 2016
-
$1.39 B(+5.4%)
June 2016
-
$1.32 B(+1.2%)
Mar 2016
-
$1.30 B(+1.9%)
Dec 2015
$909.10 M(-1.9%)
$1.28 B(+3.8%)
Sept 2015
-
$1.23 B(+48.2%)
June 2015
-
$829.04 M(-16.6%)
Mar 2015
-
$994.09 M(+3.8%)
Dec 2014
$926.82 M(-21.0%)
$957.59 M(-11.2%)
Sept 2014
-
$1.08 B(+22.3%)
June 2014
-
$881.61 M(-11.0%)
Mar 2014
-
$990.27 M(+8.3%)
Dec 2013
$1.17 B(+22.4%)
$914.38 M(-2.0%)
Sept 2013
-
$932.74 M(+3.2%)
June 2013
-
$903.58 M(+7.0%)
Mar 2013
-
$844.57 M(+26.3%)
Dec 2012
$958.13 M(+0.3%)
$668.47 M(-6.9%)
Sept 2012
-
$718.18 M(+25.9%)
June 2012
-
$570.61 M(-0.6%)
Mar 2012
-
$573.92 M(+2.0%)
Dec 2011
$955.62 M
$562.46 M(-33.5%)
DateAnnualQuarterly
Sept 2011
-
$846.13 M(-3.6%)
June 2011
-
$877.51 M(+8.2%)
Mar 2011
-
$810.84 M(+6.1%)
Dec 2010
$667.15 M(-8.2%)
$764.49 M(+27.7%)
Sept 2010
-
$598.48 M(+15.9%)
June 2010
-
$516.29 M(+29.5%)
Mar 2010
-
$398.75 M(+22.9%)
Dec 2009
$727.04 M(+26.0%)
$324.51 M(+0.7%)
Sept 2009
-
$322.15 M(+11.9%)
June 2009
-
$287.88 M(+7.7%)
Mar 2009
-
$267.36 M(-10.1%)
Dec 2008
$577.09 M(+146.0%)
$297.45 M(+0.5%)
Sept 2008
-
$295.92 M(+4.7%)
June 2008
-
$282.64 M(-13.8%)
Mar 2008
-
$327.86 M(-7.0%)
Dec 2007
$234.56 M(+17.5%)
$352.46 M(+22.9%)
Sept 2007
-
$286.88 M(+16.2%)
June 2007
-
$246.84 M(+12.8%)
Mar 2007
-
$218.92 M(-21.1%)
Dec 2006
$199.60 M(+60.1%)
$277.37 M(+53.9%)
Sept 2006
-
$180.20 M(-13.1%)
June 2006
-
$207.26 M(+11.0%)
Mar 2006
-
$186.67 M(+11.9%)
Dec 2005
$124.66 M(+29.0%)
$166.76 M(+13.5%)
Sept 2005
-
$146.89 M(+16.0%)
June 2005
-
$126.63 M(+6.1%)
Mar 2005
-
$119.31 M(+8.0%)
Dec 2004
$96.67 M(+7.7%)
$110.49 M(+2.3%)
Sept 2004
-
$107.96 M(+13.2%)
June 2004
-
$95.39 M(+8.0%)
Mar 2004
-
$88.29 M(-1.6%)
Dec 2003
$89.78 M(+110.2%)
$89.72 M(-14.8%)
Sept 2003
-
$105.33 M(-5.3%)
June 2003
-
$111.20 M(+0.9%)
Mar 2003
-
$110.20 M(-22.3%)
Dec 2002
$42.71 M(-70.2%)
$141.86 M(-8.6%)
Sept 2002
-
$155.16 M(-8.6%)
June 2002
-
$169.70 M(+119.4%)
Mar 2002
-
$77.35 M(+12.1%)
Dec 2001
$143.12 M(+401.7%)
$69.00 M(-35.5%)
Sept 2001
-
$107.02 M(-37.8%)
June 2001
-
$172.12 M(-13.0%)
Mar 2001
-
$197.76 M(-11.0%)
Dec 2000
$28.52 M(+296.2%)
$222.12 M(-7.8%)
Sept 2000
-
$240.84 M(+115.8%)
June 2000
-
$111.60 M(-5.8%)
Mar 2000
-
$118.50 M(+124.9%)
Dec 1999
$7.20 M(+278.9%)
$52.70 M(-11.9%)
Sept 1999
-
$59.80 M(+3.5%)
June 1999
-
$57.80 M(+272.9%)
Mar 1999
-
$15.50 M
Dec 1998
$1.90 M
-

FAQ

  • What is United Therapeutics annual total current assets?
  • What is the all time high annual current assets for United Therapeutics?
  • What is United Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for United Therapeutics?
  • What is United Therapeutics quarterly current assets year-on-year change?

What is United Therapeutics annual total current assets?

The current annual current assets of UTHR is $3.55 B

What is the all time high annual current assets for United Therapeutics?

United Therapeutics all-time high annual total current assets is $3.55 B

What is United Therapeutics quarterly total current assets?

The current quarterly current assets of UTHR is $4.00 B

What is the all time high quarterly current assets for United Therapeutics?

United Therapeutics all-time high quarterly total current assets is $4.00 B

What is United Therapeutics quarterly current assets year-on-year change?

Over the past year, UTHR quarterly total current assets has changed by +$449.40 M (+12.66%)